DAT
DAT, licence 80145414: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Designs for Health Ltd.
- NPN or DIN-HM
- 80145414
- Status
- Active licence
- Licence date
- 18 November 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Biotine Source : Biotine | 75.0 Microgrammes | Not calculated |
| tocotriénols Source : Bixa orellana - Graine | 7.5 mg | Not calculated |
| Zinc Source : Diglycinate de zinc | 7.5 mg | 15,000 µg |
| Molybdène Source : Diglycinate de molybdène (VI) | 50.0 Microgrammes | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Potency : 95.0 % Oligomeric proanthocyanidins | 25.0 mg | Not calculated |
| Manganèse Source : Diglycinate de manganèse (II) | 1.5 mg | 3,000 µg |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Acide R-alpha lipoïque | 15.0 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 50.0 Microgrammes | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Acide stéarique, Silice, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s). A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps to maintain/support the body's ability to metabolize nutrients. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) (essential) amino acid(s) involved in muscle protein synthesis. Source of (an) essential amino acid(s) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80145414
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.